178 related articles for article (PubMed ID: 28365157)
21. A pilot rating system to evaluate the quality of goal attainment scales used as outcome measures in rehabilitation.
Pradeau C; Estival S; Postal V; Laurier V; Maugard C; Isner-Horobeti ME; Mourre F; Krasny-Pacini A
Neuropsychol Rehabil; 2024 May; ():1-32. PubMed ID: 38805592
[TBL] [Abstract][Full Text] [Related]
22. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling.
Steenbeek D; Meester-Delver A; Becher JG; Lankhorst GJ
Clin Rehabil; 2005 May; 19(3):274-82. PubMed ID: 15859528
[TBL] [Abstract][Full Text] [Related]
23. Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.
Turner-Stokes L; Fheodoroff K; Jacinto J; Maisonobe P
BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794582
[TBL] [Abstract][Full Text] [Related]
24. [The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients].
Khat'kova SE; Khasanova DR; Korenko LA; Antipova LN; Shperling LP; Popov DV; Pokhabov DV; Poznyakova EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):89-97. PubMed ID: 26356520
[TBL] [Abstract][Full Text] [Related]
25. The use of goal attainment scaling in a geriatric care setting.
Stolee P; Rockwood K; Fox RA; Streiner DL
J Am Geriatr Soc; 1992 Jun; 40(6):574-8. PubMed ID: 1587973
[TBL] [Abstract][Full Text] [Related]
26. [Measuring outcome in spasticity rehabilitation].
Fheodoroff K; Wissel J; Entner T; Freimüller M
Wien Klin Wochenschr; 2001; 113 Suppl 4():11-5. PubMed ID: 15506046
[TBL] [Abstract][Full Text] [Related]
27. A multi-site study of the feasibility and clinical utility of Goal Attainment Scaling in geriatric day hospitals.
Stolee P; Awad M; Byrne K; Deforge R; Clements S; Glenny C;
Disabil Rehabil; 2012; 34(20):1716-26. PubMed ID: 22397694
[TBL] [Abstract][Full Text] [Related]
28. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the feasibility of Goal Attainment Scaling as a rehabilitation outcome measure for veterans.
Lewis VJ; Dell L; Matthews LR
J Rehabil Med; 2013 Apr; 45(4):403-9. PubMed ID: 23546308
[TBL] [Abstract][Full Text] [Related]
30. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a multimodal management of prematurity-related spasticity.
Papavasiliou AS; Rapidi CA; Filiopoulos C; Rizou C; Skouteli HN
Pediatr Neurol; 2006 Dec; 35(6):400-7. PubMed ID: 17138009
[TBL] [Abstract][Full Text] [Related]
32. Goal Attainment Scaling in Outpatient Physical Therapy for Chronic Low Back Pain: Protocol for a Mixed Methods Study.
Haladay D; Ditwiler RE; Klein AB; Miro R; Lazinski M; Swisher LL; Beckstead J; Wolfson J; Hardwick D
JMIR Res Protoc; 2022 Mar; 11(3):e32457. PubMed ID: 35254282
[TBL] [Abstract][Full Text] [Related]
33. Goal attainment scaling in rehabilitation: a literature-based update.
Krasny-Pacini A; Hiebel J; Pauly F; Godon S; Chevignard M
Ann Phys Rehabil Med; 2013 Apr; 56(3):212-30. PubMed ID: 23562111
[TBL] [Abstract][Full Text] [Related]
34. Goal attainment scaling: an effective outcome measure for rural and remote health services.
Cox R; Amsters D
Aust J Rural Health; 2002 Oct; 10(5):256-61. PubMed ID: 12230434
[TBL] [Abstract][Full Text] [Related]
35. [Botulinum toxin therapy for spasticity].
Masakado Y
Brain Nerve; 2014 Sep; 66(9):1039-47. PubMed ID: 25200575
[TBL] [Abstract][Full Text] [Related]
36. Toning it down: selecting outcome measures for spasticity management using a modified Delphi approach.
Pereira S; Richardson M; Mehta S; Teasell R; Miller T
Arch Phys Med Rehabil; 2015 Mar; 96(3):518-523.e18. PubMed ID: 25449190
[TBL] [Abstract][Full Text] [Related]
37. Effects of Botulinum Toxin-A and Goal-Directed Physiotherapy in Children with Cerebral Palsy GMFCS Levels I & II.
Löwing K; Thews K; Haglund-Åkerlind Y; Gutierrez-Farewik EM
Phys Occup Ther Pediatr; 2017 Aug; 37(3):268-282. PubMed ID: 27058177
[TBL] [Abstract][Full Text] [Related]
38. Goal attainment scaling in paediatric rehabilitation: a critical review of the literature.
Steenbeek D; Ketelaar M; Galama K; Gorter JW
Dev Med Child Neurol; 2007 Jul; 49(7):550-6. PubMed ID: 17593130
[TBL] [Abstract][Full Text] [Related]
39. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
Turner-Stokes L; Ashford S
Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
[TBL] [Abstract][Full Text] [Related]
40. The practical use of goal attainment scaling for people with acquired brain injury who receive cognitive rehabilitation.
Bouwens SF; van Heugten CM; Verhey FR
Clin Rehabil; 2009 Apr; 23(4):310-20. PubMed ID: 19179354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
